Colorectal cancer: risk factors and recommendations for early detection.
Spurred by mounting evidence that the detection and treatment of early-stage colorectal cancers and adenomatous polyps can reduce mortality, Medicare and some other payors recently authorized reimbursement for colorectal cancer screening in persons at average risk for this malignancy. A collaborative group of experts convened by the U.S. Agency for Health Care Policy and Research has recommended screening for average-risk persons over the age of 50 years using one of the following techniques: fecal occult blood testing each year, flexible sigmoidoscopy every five years, fecal occult blood testing every year combined with flexible sigmoidoscopy every five years, double-contrast barium enema every five to 10 years or colonoscopy every 10 years. Screening of persons with risk factors should begin at an earlier age, depending on the family history of colorectal cancer or polyps. These recommendations augment the colorectal cancer screening guidelines of the American Academy of Family physicians. Recent advances in genetic research have made it possible to identify persons at high risk for colorectal cancer because of an inherited predisposition to develop this malignancy. These patients require aggressive screening, usually by lower endoscopy performed at an early age. In some patients, genetic testing can guide screening and may be cost-effective.
Read
T E
TE
Washington University School of Medicine, St. Louis, Missouri, USA.
Kodner
I J
IJ
D011125:Adenomatous Polyposis Coli / Q000150:complications; D000367:Age Factors; D000465:Algorithms; D001466:Barium Sulfate; D003093:Colitis, Ulcerative / Q000150:complications; D003113:Colonoscopy; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000209:etiology / Q000517:prevention & control*; D003123:Colorectal Neoplasms, Hereditary Nonpolyposis / Q000150:complications; D003287:Contrast Media; D003663:Decision Trees; D004733:Enema; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D009780:Occult Blood; D011159:Population Surveillance / Q000379:methods*; D012307:Risk Factors; D012812:Sigmoidoscopy
D003287:Contrast Media; D001466:Barium Sulfate